Label: SENNA- sennosides tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated June 26, 2025

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient (in each tablet)

    Sennosides 8.6 mg

  • Purpose

    Stimulant Laxative

  • Uses

    • relieve occasional constipation (irregularity)
    • this product generally produces a bowel movement in 6 to 12 hours
  • Warnings

    Do not use

    • Lasative products for longer than 1 week unless directed by a doctor
  • ASK DOCTOR

    Ask a doctor before use if you have

    • stomach pain
    • nausea
    • vomiting
    • noticed a sudden change in bowel habits that continues over a period of 2 weeks
  • STOP USE

    Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact a Posion Control Center right away.

  • Other information

    • each tablet contains: calcium 4 mg, sodium 3 mg
    • store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)
  • Inactive ingredients

    colloidal sillicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose

  • Questions or comments?

    Call 516-341-0666

    8:30am-4:30pm ET. Mon-Fri

  • Directions

    take preferably at bedtime or as directed by a doctor

    do not exceed maximum dosage

    agestarting dosagemaximum dosage
    adults and children 12 years of age or older2 tablets once a day4 tablets twice a day
    children 6 to under 12 years1 tablet once a day2 tablets twice a day
    children 2 to under 6 years1/2 tablet once a day1 tablet twice a day
    children under 2 yearsask a doctorask a doctor


  • HOW SUPPLIED

    Sennosides 8.6 mg: color brown (light), shape round, imprint code S5.

    NDC: 71335-2360-1: 100 Tablets in a BOTTLE

    NDC: 71335-2360-2: 60 Tablets in a BOTTLE

    NDC: 71335-2360-3: 120 Tablets in a BOTTLE

    NDC: 71335-2360-4: 56 Tablets in a BOTTLE

    NDC: 71335-2360-5: 30 Tablets in a BOTTLE

    NDC: 71335-2360-6: 90 Tablets in a BOTTLE

    NDC: 71335-2360-7: 10 Tablets in a BOTTLE

    Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

    Repackaged/Relabeled by:
    Bryant Ranch Prepack, Inc.
    Burbank, CA 91504

  • PRINCIPAL DISPLAY PANEL

    Sennosides 8.6mg Tablet

    Label
  • INGREDIENTS AND APPEARANCE
    SENNA 
    sennosides tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71335-2360(NDC:69618-064)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN) SENNOSIDES A AND B8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Product Characteristics
    Colorbrown (light) Scoreno score
    ShapeROUNDSize9mm
    FlavorImprint Code S5
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71335-2360-1100 in 1 BOTTLE; Type 0: Not a Combination Product06/26/2025
    2NDC:71335-2360-260 in 1 BOTTLE; Type 0: Not a Combination Product06/26/2025
    3NDC:71335-2360-3120 in 1 BOTTLE; Type 0: Not a Combination Product06/26/2025
    4NDC:71335-2360-456 in 1 BOTTLE; Type 0: Not a Combination Product06/26/2025
    5NDC:71335-2360-530 in 1 BOTTLE; Type 0: Not a Combination Product06/26/2025
    6NDC:71335-2360-690 in 1 BOTTLE; Type 0: Not a Combination Product06/26/2025
    7NDC:71335-2360-710 in 1 BOTTLE; Type 0: Not a Combination Product06/26/2025
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00708/01/2020
    Labeler - Bryant Ranch Prepack (171714327)
    Registrant - Bryant Ranch Prepack (171714327)
    Establishment
    NameAddressID/FEIBusiness Operations
    Bryant Ranch Prepack171714327REPACK(71335-2360) , RELABEL(71335-2360)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!